Tracy Rarick
Corporate Officer/Principal bij WINDTREE THERAPEUTICS, INC.
Oorsprong van het eerstegraads netwerk van Tracy Rarick
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 21 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Tracy Rarick via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
Wyeth Corp.
 Wyeth Corp. Pharmaceuticals: MajorHealth Technology Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal President Chief Tech/Sci/R&D Officer | |
Centocor, Inc.
 Centocor, Inc. Medical SpecialtiesHealth Technology Centocor, Inc. manufactures healthcare products. Its products include avakine & reopro. The company was founded in 1979 by Hubert J. P. Schoemaker & Michael A. Wall and is headquartered in Horsham, PA. | Medical Specialties | Director of Finance/CFO Sales & Marketing | |
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Corporate Officer/Principal Sales & Marketing | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| COVANCE INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| ROCKWELL MEDICAL, INC. | Medical Specialties | Chief Executive Officer | |
| STANDARD BIOTOOLS INC. | Medical Specialties | Director/Board Member | |
Santarus, Inc.
 Santarus, Inc. Pharmaceuticals: MajorHealth Technology Santarus, Inc. operates as a biopharmaceutical company. The company was founded on December 6, 1996 and is headquartered in Bridgewater, NJ. | Pharmaceuticals: Major | Director/Board Member | |
Wyeth Pharmaceuticals LLC
 Wyeth Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Wyeth Pharmaceuticals LLC develops pharmaceutical, biotechnology and vaccine technologies. The company was registered on May 5, 2003 and is headquartered in Collegeville, PA. | Pharmaceuticals: Major | President Corporate Officer/Principal Corporate Officer/Principal | |
Aquilo Partners LP
 Aquilo Partners LP Investment ManagersFinance Aquilo Partners LP provides corporate finance, mergers & acquisitions and strategic advisory services to public and private life science companies. It also provides buyside M&A, sellside M&A, partnering and private placement. The company was founded by Brian Polzak, John Rumsey and James Zanze in 2001 and is located in San Francisco, CA. | Investment Managers | Corporate Officer/Principal | |
| AEGERION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Operating Officer Corporate Officer/Principal | |
| OCULAR THERAPEUTIX, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
GSK Equity Investments Ltd.
 GSK Equity Investments Ltd. Investment ManagersFinance GSK Equity Investment Ltd (GSK Equity) is a venture capital firm a subsidiary of GlaxoSmithKline Plc founded in 1985. The firm is headquartered in Reedwood City, California. | Investment Managers | Private Equity Analyst | |
| Stanford University | College/University | Graduate Degree | |
| MITSUBISHI TANABE PHARMA CORPORATION | Pharmaceuticals: Other | Corporate Officer/Principal | |
| AUTO ITALIA HOLDINGS LIMITED | Specialty Stores | Director/Board Member | |
KuDOS Pharmaceuticals Ltd.
 KuDOS Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology KuDOS Pharmaceuticals Ltd. discovers and develops pharmaceutical products. Its products are used to treat DNA damage sensing, signaling, viral disease, ischaemia, and repair to address unmet medical needs in cancer treatment. The company was founded by Stephen Jackson on December 12, 1997 and is headquartered in Cambridge, UK. | Pharmaceuticals: Major | Director/Board Member | |
BVP Partners LLC
 BVP Partners LLC Investment ManagersFinance BVP Partners LLC (BVP Partners) is a venture capital firm founded in the year 2003. The firm headquarters in Princeton. | Investment Managers | Private Equity Investor | |
GlaxoSmithKline, Inc.
 GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology GlaxoSmithKline, Inc. manufactures and markets pharmaceutical products. The company develops medicines to prevent infections that cause serious medical problems such as respiratory illnesses, diabetes, viral control, infections, and central nervous system disorders. The company is headquartered in Mississauga, Canada. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| University of Cincinnati (Ohio) | College/University | Doctorate Degree | |
| University of Iowa | College/University | Undergraduate Degree | |
| Villanova University | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| ALAUNOS THERAPEUTICS, INC. | Biotechnology | Chairman | |
Ben Franklin Technology Partners /Ventures/
 Ben Franklin Technology Partners /Ventures/ Investment ManagersFinance Ben Franklin Technology Partners /Ventures/ (Ben Franklin Tech Partners) is a venture Capital firm founded in 1982. The firm is headquartered in Philadelphia, Pennsylvania. | Investment Managers | Investment Committee Member | |
INO Therapeutics LLC
 INO Therapeutics LLC Pharmaceuticals: MajorHealth Technology INO Therapeutics LLC engages in the development of pharmaceutical drugs. The company is headquartered in Hampton, NJ. | Pharmaceuticals: Major | Sales & Marketing | |
CDI Bioscience, Inc.
 CDI Bioscience, Inc. BiotechnologyHealth Technology CDI Bioscience, Inc. has developed an innovative technology for increased yield of bioproducts, manufactured in cellular systems. Genetic engineering technology is used to control the metabolism of cells, thus shifting the cell from explicative to production mode (RP Shift®). In particular, this technology has been designed for use in mammalian cells, unlocking their potential to produce proteins, peptides and enzymes. The current design of the technology can be readily translated to bacterial and yeast cellular systems for the production of commercial grade bio products. Recombinant therapeutic proteins have proven to be invaluable biopharmaceuticals for the treatment of chronic and life-threatening diseases. While exceptionally effective, the dosage requirements are generally very high for the required treatment. Several hundred milligrams of protein per administration is common and multiple doses are often required and being protein based drugs, they can only be produced by living cells which is why increasing production yield is a challenge. CDI Bioscience has developed a patented technology that dramatically improves the product yield in biopharmaceutical manufacturing. CDI's core technology, RP Shift®, solves a number of intermediate problems in the development of biopharmaceutical products by significantly boosting the productivity and viability of production cells. | Biotechnology | Director/Board Member | |
| TREVENA, INC. | Pharmaceuticals: Major | Comptroller/Controller/Auditor Corporate Officer/Principal | |
Inomax LLC (Florida)
 Inomax LLC (Florida) Investment ManagersFinance Inomax LLC is an American venture capital company. | Investment Managers | Corporate Officer/Principal | |
Datex-Ohmeda, Inc.
 Datex-Ohmeda, Inc. Industrial ConglomeratesProducer Manufacturing Part of General Electric Co., Datex-Ohmeda, Inc. develops and manufactures medical equipment. The private company is based in Madison, WI. | Industrial Conglomerates | Corporate Officer/Principal | |
GlaxoSmithKline LLC
 GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
Corridor Pharmaceuticals, Inc.
 Corridor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Corridor Pharmaceuticals, Inc. develops and manufactures biopharmaceutical products. The company was founded on February 1, 2008 and is headquartered in Lutherville, MD | Pharmaceuticals: Major | Chief Executive Officer | |
| Olin Business School | College/University | Masters Business Admin | |
ImmusanT, Inc.
 ImmusanT, Inc. Medical SpecialtiesHealth Technology ImmusanT, Inc. develops a new class of therapeutic vaccines to change the lives of people living with autoimmune diseases. Its Epitope-Specific Immuno-Therapy platform provides a precision medicine approach to restoring immune tolerance across a range of diseases, including celiac disease and type 1 diabetes. The firm’s product Nexvax2, protects celiac disease patients against the debilitating effects of gluten. The company was by Leslie J. Williams and Robert P. Anderson founded in December 2010 and is headquartered in Cambridge, MA. | Medical Specialties | Founder | |
The Capital Network, Inc.
 The Capital Network, Inc. Miscellaneous Commercial ServicesCommercial Services The Capital Network, Inc. is a private company based in Wellesley, MA that provides founder-focused fundraising education programs. The company aims to create a more inclusive and accessible funding ecosystem to support female and other first-time founders of early stage startups. The company offers three programs: the Fellowship for Female Founders, Fundraising Readiness Workshops, and the Investment and Inclusion Series. The Fellowship for Female Founders is a six-month program that has helped over 90+ female founders raise over $85m in capital. The company also offers ongoing workshops for first-time startup founders and a series of honest conversations to bring about meaningful systemic change. The Capital Network has a network of 300+ investors and sponsors who help them make the fundraising ecosystem work for everybody. The company was founded by Ashkan Afkhami and Chula Reynolds. | Miscellaneous Commercial Services | Director/Board Member | |
| HUMORIGIN BIOTECHNOLOGY CORP | Biotechnology | Chairman | |
| LEGEND BIOTECH CORPORATION | Pharmaceuticals: Major | Founder | |
Oncxerna Therapeutics, Inc.
 Oncxerna Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Oncxerna Therapeutics, Inc. develops oncology drugs. The firm uses RNA-based biomarker platform. It focuses on clinical-stage therapies. The company was founded by Laura E. Benjamin in 2018 and is headquartered in Boston, MA. | Pharmaceuticals: Major | Director/Board Member | |
Tactiva Therapeutics LLC
 Tactiva Therapeutics LLC Pharmaceuticals: MajorHealth Technology Tactiva Therapeutics LLC operates as a development stage immuno-oncology company. The firm engages in developing the next generation of cancer immunotherapies by utilizing a new approach to cell therapy. The company was founded by Matthew E. Colpoys Jr., Richard C. Koya, and Kunle Odunsi and is headquartered in Buffalo, NY. | Pharmaceuticals: Major | Chairman | |
| ZHAOKE OPHTHALMOLOGY LIMITED | Pharmaceuticals: Major | Director/Board Member | |
| ASSERTIO HOLDINGS, INC. | Pharmaceuticals: Major | Chief Operating Officer | |
Chime Biologics Ltd.
 Chime Biologics Ltd. Miscellaneous Commercial ServicesCommercial Services Chime Biologics Ltd. is a leading Contract Development and Manufacturing Organization (CDMO) that provides customer-centric and cost-effective outsourcing services for biopharmaceutical development and manufacturing. The company is based in Wuhan, China, and its world's first GE Kubio facility is located at Wuhan's Bio-Lake Biotech Industry Development Zone, with a clear path to expand the total capacity up to 140,000+ liters in the near future. The Chinese company has introduced the world's first modular biopharmaceutical plant, Kubio, which empowers its partners' success in biologics from cell line development to commercial manufacturing. Chime Biologics is committed to making cutting-edge biomedicines affordable and accessible to all patients, fulfilling its commitment to human health. Chime Biologics is ISO 14001:2015 and ISO 45001:2018 certified and has been providing customers with clinical materials for pre-clinical and clinical stages worldwide since 2016. | Miscellaneous Commercial Services | Chairman | |
| ORION BIOTECH OPPORTUNITIES CORP. | Financial Conglomerates | Founder | |
| CONNECT BIOPHARMA HOLDINGS LIMITED | Pharmaceuticals: Major | Director/Board Member | |
| ZAI LAB LIMITED | Biotechnology | Founder |
Statistieken
Internationaal
| Verenigde Staten | 42 |
| Kaaimaneilanden | 3 |
| China | 3 |
| Japan | 2 |
| Hongkong | 2 |
Sectoraal
| Health Technology | 35 |
| Finance | 7 |
| Consumer Services | 6 |
| Commercial Services | 3 |
| Retail Trade | 2 |
Operationeel
| Director/Board Member | 91 |
| Corporate Officer/Principal | 65 |
| Independent Dir/Board Member | 24 |
| President | 22 |
| Undergraduate Degree | 19 |
Sterkste connecties
| Insiders | |
|---|---|
| Zuie Chin Huang | 40 |
| Bruce Peacock | 28 |
| John R. Leone | 21 |
| Mark Strobeck | 21 |
| Leslie Williams | 19 |
| Robert Scott | 15 |
| Joseph M. Mahady | 14 |
| Evan Loh | 14 |
| John Hamill | 13 |
| Brian Schreiber | 11 |
| Diane Carman | 9 |
| Craig Fraser | 7 |
| Eric Curtis | 7 |
| John Tattory | 6 |
| Steven Simonson | 6 |
- Beurs
- Insiders
- Tracy Rarick
- Bedrijfsconnecties
